Health Care & Life Sciences » Biotechnology | Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
110.87 M
Public Float
103.16 M
Pluristem Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.32
Market Cap
$88.22 M
Shares Outstanding
149.74 M
Public Float
102.6 M

Profile

Address
MATAM Advanced Technology Park
Haifa HA 31905
Israel
Employees -
Website http://www.pluristem.com
Updated 07/08/2019
Pluristem Therapeutics, Inc. is a biotechnology company, which engages in the provision of cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The company focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others.

Financials

View All

Zami Aberman
Chairman & Co-Chief Executive Officer
Yaky Yanay
President, Co-Chief Executive Officer & Director